Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance

Online download statistics by month:

Online download statistics by month: July 2022 to April 2024

	Abstract	Full	Pdf
Jul 2022	499	22	24
Aug 2022	462	18	24
Sep 2022	961	45	29
Oct 2022	842	43	29
Nov 2022	630	20	21
Dec 2022	269	7	6
Jan 2023	285	10	13
Feb 2023	262	9	12
Mar 2023	184	4	6
Apr 2023	172	11	9
May 2023	285	20	13
Jun 2023	149	9	9
Jul 2023	173	6	9
Aug 2023	145	3	3
Sep 2023	321	10	9
Oct 2023	154	8	4
Nov 2023	208	9	5
Dec 2023	268	15	8
Jan 2024	356	8	4
Feb 2024	151	6	5
Mar 2024	178	7	4
Apr 2024	229	12	8
Total	7183	302	254